tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Cumberland Pharmaceuticals Advances Ifetroban Study for SSc and SSc-PAH
PremiumCompany AnnouncementsCumberland Pharmaceuticals Advances Ifetroban Study for SSc and SSc-PAH
3M ago
Cumberland shares latest results from its Phase 2 FIGHT DMD trial
Premium
The Fly
Cumberland shares latest results from its Phase 2 FIGHT DMD trial
3M ago
Cumberland announces partnership with Qureight
Premium
The Fly
Cumberland announces partnership with Qureight
5M ago
Cumberland options imply 26.1% move in share price post-earnings
PremiumThe FlyCumberland options imply 26.1% move in share price post-earnings
7M ago
Cumberland announces NMPA approval of Vibativ injection in China
Premium
The Fly
Cumberland announces NMPA approval of Vibativ injection in China
7M ago
Cumberland reports ‘positive’ results from Phase 2 FIGHT DMD trial
Premium
The Fly
Cumberland reports ‘positive’ results from Phase 2 FIGHT DMD trial
8M ago
Cumberland receives FDA orphan, RPDD designation for Ifetroban
PremiumThe FlyCumberland receives FDA orphan, RPDD designation for Ifetroban
11M ago
Cumberland announces publication comparing Caldolor and ketorolac
Premium
The Fly
Cumberland announces publication comparing Caldolor and ketorolac
11M ago
Cumberland files $100M mixed securities shelf
Premium
The Fly
Cumberland files $100M mixed securities shelf
2y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100